FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment
'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). The news comes after decades of psychedelic advocates urging regulators to give the drug medical acceptance.